In our study, we used an Fc-silent IgG2σ variant of hu5F9 to investigate the impact of myeloid checkpoint blockade on CD38 antibody mediated T-ALL cell cytotoxicity. Here, CD38 is linked to acute lymphoblastic leukemia.